Prefer to talk to a pro?

Call today, and let us connect you with the perfect merchant!

1-844-686-2616

Call today, and let us connect you with the perfect merchant!


Top Professional Services in Pflugerville, TX

Prefer to talk to a pro?

Call today, and let us connect you with the perfect merchant!

1-844-686-2616

Call today, and let us connect you with the perfect merchant!

Where do you need Professional Services ?

Updates & tips

CDSCO Guideline Approved for Medical Devices Safety & Performance

CDSCO guideline approved under the Central Drugs Standard Control Organization (CDSCO) is the Central Drug Authority for discharging functions assigned to the Central Government under the Drugs and Cosmetics Act. One of the major functions of CDSCO is approval of new drugs in the country. During the month of March 2018, CDSCO guideline was approved on the following issuance of the CDSCO guidelines under the provisions of the Medical Devices Rules, 2017 on Essential Principles for safety and performance ofmedical devices CDSCO.  The new medical device rule “MDR 2017, India” has come into result from January 2018. Under control with that, the CDSCO (Central Drug Standard Control Organization) has recently been releasing guidance paper, CDSCO guideline report and various other important updates to allocate unalterable guidance for use in the manufacturing and registration ofmedical devices which are planned to be sold in India. Just like that, CDSCO has released anew draft guidance document, which concisely highlights the essential principles for safety and production of various medical devices (MDs) based on rule 6 of MDR 2017. Normally there are 3 levels of the standard used to meet the medical devices’ essential principles for safety and performance. These need to be examined as a whole i.e. basic standard, group standard, and product standard. Basic standards are standards specifying elemental concepts, principles, with consideration to general safety which is relevant to a wide range of products, whereas group standards consist features applicable to families of similar products making reference as far as possible to basic standards. Eventually, product standards indicate requisite safety and performance of specific products making reference as far as possible, to basic standards and group standards. Contact details –  Phone no - 9325283428 Mail - dm@operonstrategist.com Visit us -https://www.operonstrategist.com/cdsco-guideline?utm_source=web%202%20submission&utm_medium=web%202%20%20page&utm_campaign=web%202%20%20submission 

FDA medical device approval process step-by-step guide

If you are looking for FDA medical device approval process for your medicinal device then you are in the right place. Here is a complete step-by-step guide for FDA medical device approval process. Medical devices, from ideation to post-launch assessment, are directed in the United States by the U.S. Food and Drug Administration (FDA) under the Medical Device Regulation Act of 1976 an ensuing revision to the Federal Food, Drug and Cosmetics Act of 1938. All organizations intending to move the medical device in the United States need to officially list their product with the US FDA. Most Class I devices can be self-enrolled but a great amount of Class II devices require a510(k) submission. And for Class III devices, a Pre-Market (PMA) submission is required. Medical Device Regulations in the USA In the USA, medical devices are managed by the Food and Drug Administration (FDA) with an expected to guarantee the safety and effectiveness of the devices. TheCenter for Devices and Radiological Health (CDRH)is an FDA segment and observes after this program. The FDA’s medical device regulatory pathways — for premarket audit, clearance, and approval are built on three classifications, which demonstrate the level of regulatory control important to guarantee a device’s safety and adequacy. Class I devices are examined as low-risk generally safe, and many are excluded from the regulatory process. Class II devices require remarkable controls for “labelling, guidance, tracking, plan, performance standards, and post-market observation,” and most require premarket notification 510(k) to appraise substantial equivalence (having the equivalent proposed use and technological attributes) to a lawfully marketed device. Class III devices generally continue or support life, are embedded, or present a remarkable risk of illness or injury. Majority of class III devices need premarket approval (PMA), which investigate a variety of factors in weighing the potential health benefits from the intentional use of a device versus the possible risks. Read more -https://www.operonstrategist.com/fda-medical-device-approval-process/?utm_source=web%202%20submission&utm_medium=web%202%20%20page&utm_campaign=web%202%20%20submission operon strategist provide FDA 510 k Consultant services to medical device manufacturer.US FDA 510 k Submission and approval. Contact details – Phone no - 9325283428 Mail - dm@operonstrategist.com Visit us -https://www.operonstrategist.com/510k-clearance-premarket-approval/?utm_source=web%202%20submission&utm_medium=web%202%20%20page&utm_campaign=web%202%20%20submission

510k Premarket Notification | Ultrasonic Diathermy Devices

Guidance for Industry,Food and Drug AdministrationStaff. Document issued on April 16, 2018. Among other requirements in the Federal Food, Drug, and Cosmetic Act (FD&C Act) and its implementing regulations, ultrasonic diathermy devices, also known as ultrasonic therapy or physiotherapy products, must comply with21 CFR Part 1010 and 1050.10. This guidance document describes FDA’s recommendations for the performance standard requirements in 21 CFR 1050.10 particular to ultrasonic diathermy devices when a manufacturer has otherwise complied with certain International Electrotechnical Commission (IEC) standards. Scope Of Ultrasonic DiathermyProducts The scope of this document is limited to ultrasonic diathermy products regulated under 21 CFR 890.5300(a), product codes IMI and PFW, and are class II devices. This guidance is applicable to ultrasonic diathermy (physiotherapy) devices for use in applying therapeutic deep heat for selected medical conditions such as relief of pain, muscle spasms, and joint contractures. This guidance only relates to equipment employing ultrasonic energy at a frequency beyond 20 kilohertz using a single plane circular transducer per treatment head producing non-convergent beams perpendicular to the face of the treatment head (i.e., collimated or divergent). Other medical devices that include the use of ultrasound are regulated outside of 21 CFR 890.5300(a) and are excluded from the scope of this guidance. Excluded medical devices include, but are not limited to: Devices in which ultrasound waves are intended to destroy conglomerates (for example stones in the kidneys or the bladder) or tissue of any type; Devices in which a tool is driven by ultrasound (for example surgical scalpels, phacoemulsifiers, dental scalers or intracorporeal lithotripters); Devices in which ultrasound waves are intended to sensitize tissue to further therapies (for example radiation or chemotherapy); Devices in which ultrasound waves are intended to treat cancerous (i.e., malignant) or pre-cancerous tissue, or benign masses, such as High Intensity Focused Ultrasound (HIFU) or High Intensity Therapeutic Ultrasound (HITU); and Devices in which ultrasound is intended for aesthetic purposes.